Evidence map›Paper›PMID 36883849›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

MicroRNA-155 Plays Selective Cell-Intrinsic Roles in Brain-Infiltrating Immune Cell Populations during Neuroinflammation.

Jacob W Thompson, Ruozhen Hu, Thomas B Huffaker, Andrew G Ramstead, H Atakan Ekiz, Kaylyn M Bauer, William W Tang, Arevik Ghazaryan, June L Round, Robert S Fujinami and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Jacob W ThompsonDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.ORCID 0000-0002-0952-5765
Ruozhen HuDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
Thomas B HuffakerDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
Andrew G RamsteadDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
H Atakan EkizIzmir Institute of Technology, The Department of Molecular Biology and Genetics Gulbahce, Urla, Izmir.
Kaylyn M BauerDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.ORCID 0000-0002-5498-9083
William W TangDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
Arevik GhazaryanDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
June L RoundDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
Robert S FujinamiDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
Ryan M O'ConnellDepartment of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
University of Utah · USIzmir Institute of Technology · TR

Funding

MicroRNA regulation of chronic inflammation during agingR01AG079477 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Micah J Drummond, Ryan M O'Connell · 2022 to 2026
$3.0M
The Neuroimmunology Training Program at the University of UtahT32NS115664 · NINDS · UNIVERSITY OF UTAH · PI O'CONNELL, RYAN M, WILCOX, KAREN S · 2020 to 2024
$988k
T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1F30CA260977 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI TANG, WILLIAM WEIHAO · 2021 to 2025
$252k
NCI NIH HHS F30 CA260977NIA NIH HHS R01 AG079477NINDS NIH HHS T32 NS115664
6 · The paper itself

Abstract

The proinflammatory microRNA-155 (miR-155) is highly expressed in the serum and CNS lesions of patients with multiple sclerosis (MS). Global knockout (KO) of miR-155 in mice confers resistance to a mouse model of MS, experimental autoimmune encephalomyelitis (EAE), by reducing the encephalogenic potential of CNS-infiltrating Th17 T cells. However, cell-intrinsic roles for miR-155 during EAE have not been formally determined. In this study, we use single-cell RNA sequencing and cell-specific conditional miR-155 KOs to determine the importance of miR-155 expression in distinct immune cell populations. Time-course single-cell sequencing revealed reductions in T cells, macrophages, and dendritic cells (DCs) in global miR-155 KO mice compared with wild-type controls at day 21 after EAE induction. Deletion of miR-155 in T cells, driven by CD4 Cre, significantly reduced disease severity similar to global miR-155 KOs. CD11c Cre-mediated deletion of miR-155 in DCs also resulted in a modest yet significant reduction in the development of EAE, with both T cell- and DC-specific KOs showing a reduction in Th17 T cell infiltration into the CNS. Although miR-155 is highly expressed in infiltrating macrophages during EAE, deletion of miR-155 using LysM Cre did not impact disease severity. Taken together, these data show that although miR-155 is highly expressed in most infiltrating immune cells, miR-155 has distinct roles and requirements depending on the cell type, and we have demonstrated this using the gold standard conditional KO approach. This provides insights into which functionally relevant cell types should be targeted by the next generation of miRNA therapeutics.

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalMicroRNAsMultiple SclerosisAnimalsBrainMiceMice, Inbred C57BLMice, KnockoutNeuroinflammatory DiseasesTh17 CellsMicroRNAsMirn155 microRNA, mouse

Identifiers

PMID36883849
PMCPMC10305808
OpenAlexW4323535718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.